PAREXEL INTERNATIONAL TO PRESENT AT UBS GLOBAL HEALTHCARE SERVICES CONFERENCE
BOSTON, MA, February 9, 2006 — PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the UBS Global Healthcare Services Conference at The Grand Hyatt in New York City. Josef von Rickenbach, Chairman and Chief Executive Officer, will be making a formal presentation on PAREXEL at 4:30 p.m. ET on Tuesday, February 14th.
A live webcast of this presentation will be available on the UBS website located at www.ibb.ubs.com. Find the Conferences link in the middle right side of the page, click on the graphic link and then follow the link for Webcast next to the Global Healthcare Services Conference heading. After the conference, the webcast will be available until March 15, 2006.
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, Clinical Trial Management Systems (CTMS), Interactive Voice Response Systems (IVRS) and integration services. Headquartered near Boston, Massachusetts, PAREXEL operates in 51 locations throughout 39 countries around the world, and has approximately 5,360 employees. For more information about PAREXEL, visit the Company’s website at: www.PAREXEL.com.
PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of their respective business and are hereby acknowledged.